Comparing diabetes medications: where do we set the bar?

  title={Comparing diabetes medications: where do we set the bar?},
  author={Kasia J. Lipska and Harlan M. Krumholz},
  journal={JAMA internal medicine},
  volume={174 3},
More than 25 million Americans have type 2 diabetes mellitus and face decisions about which medications to use to lower glucose levels. These decisions are increasingly complex (now involving 12 different classes of glucose-lowering agents) and increasingly costly (resulting in over $18 billion in annual expenditures1). Yet, despite the enormous health and economic implications of these decisions, there are few comparative effectiveness outcomes studies to guide clinical practice. The major… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 83 times over the past 90 days. VIEW TWEETS